Clinical Trials Browser

Phase 2 × Completed × sepantronium × Clear all

NCT01007292 2015-10-19

A Study of YM155 Plus Rituximab in Subjects With Non-Hodgkin's Lymphoma Who Have Received Prior Treatment

Phase 2 Completed

Lymphoma, Non-Hodgkin, Recurrence

NCT00818480 2015-09-04

An Extension Study Administering YM155 to Subjects Previously Enrolled in Another Protocol Administering YM155

Phase 2 Completed

DermatologicGenitourinaryLymphoid

Lymphoma, Lymphoma, Non-Hodgkin, Melanoma, Prostatic Neoplasms

NCT01009775 2015-09-04

A Study of YM155 Plus Docetaxel in Subjects With Stage III (Unresectable) or Stage IV Melanoma

Phase 2 Completed

Melanoma

NCT01038804 2013-09-18

A Study of YM155 Plus Docetaxel as First-Line Treatment in Subjects With HER2 Negative Metastatic Breast Cancer

Phase 2 Completed

Breast Neoplasms, Neoplasm Metastasis

NCT00257478 2012-06-07

A Study for the Treatment of Hormone Refractory Prostate Cancer (HRPC) in Patients Previously Treated With Chemotherapy

Phase 2 Completed

Prostatic Neoplasms

NCT00281541 2012-06-07

A Study for the Treatment of Unresectable Stage III or Metastatic Stage IV Melanoma

Phase 2 Completed

Melanoma

NCT00328588 2008-01-02

LUCY: A Study for the Treatment of Non-Small Cell Lung Cancer (NSCLC) in Patients Previously Treated With Chemotherapy

Phase 2 Completed

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms